OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and neurodegenerative diseases, today announced the appointment of Steve Chen, JD, PhD, as General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results